Literature DB >> 23390173

Fatal neuroinflammation in a case of multiple sclerosis with anti-natalizumab antibodies.

Anders Svenningsson1, Ann M Dring, Anna Fogdell-Hahn, Iwan Jones, Elin Engdahl, Malin Lundkvist, Thomas Brännström, Jonathan D Gilthorpe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23390173     DOI： 10.1212/WNL.0b013e3182840be3

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

Review 1.  Established and Emerging Immunological Complications of Biological Therapeutics in Multiple Sclerosis.

Authors:  Babak Soleimani; Katy Murray; David Hunt
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.606

2.  TCPro: an In Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity.

Authors:  Osman N Yogurtcu; Zuben E Sauna; Joseph R McGill; Million A Tegenge; Hong Yang
Journal:  AAPS J       Date:  2019-08-02       Impact factor: 4.009

Review 3.  Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases.

Authors:  Aigli G Vakrakou; Maria-Evgenia Brinia; Ioanna Svolaki; Theodore Argyrakos; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Front Neurol       Date:  2022-03-15       Impact factor: 4.003

4.  Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ.

Authors:  Kirsty E Waddington; Artemis Papadaki; Leda Coelewij; Marsilio Adriani; Petra Nytrova; Eva Kubala Havrdova; Anna Fogdell-Hahn; Rachel Farrell; Pierre Dönnes; Inés Pineda-Torra; Elizabeth C Jury
Journal:  Front Immunol       Date:  2020-07-17       Impact factor: 7.561

5.  10th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals.

Authors:  S Tourdot; A Abdolzade-Bavil; J Bessa; P Broët; A Fogdell-Hahn; M Giorgi; V Jawa; K Kuranda; N Legrand; S Pattijn; J A Pedras-Vasconcelos; A Rudy; P Salmikangas; D W Scott; V Snoeck; N Smith; S Spindeldreher; D Kramer
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

6.  Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases.

Authors:  Aigli G Vakrakou; Dimitrios Tzanetakos; Maria-Eleptheria Evangelopoulos; Theodore Argyrakos; John S Tzartos; Maria Anagnostouli; Elissavet Andreadou; Georgios Koutsis; Georgios Velonakis; Panagiotis Toulas; Elias Gialafos; Antonios Dimitrakopoulos; Erasmia Psimenou; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Ther Adv Neurol Disord       Date:  2021-05-18       Impact factor: 6.570
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.